Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Circulation
|
September 12, 2000
Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway
D Kalra, G Baumgarten, Z Dibbs, et al.
Biochemical and Biophysical Research Communications
|
October 23, 1997
Keratinocytes become terminally differentiated in a process involving programmed cell death
Y Maruoka, H Harada, T Mitsuyasu, et al.
Circulation
|
March 10, 2001
Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart
F Wang, Y Seta, G Baumgarten, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 10, 2014
Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes
T Lajunen, K Hisazumi, T Kanazawa, et al.
Circulation
|
June 29, 1999
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
A Deswal, B Bozkurt, Y Seta, et al.
Research Communications in Molecular Pathology and Pharmacology
|
January 5, 2002
Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression
Y Seta, T Kanda, T Tanaka, et al.
Japanese Heart Journal
|
May 12, 2000
Therapy with the nonpeptide endothelin receptor antagonist 97-139 in a murine model of congestive heart failure: reduction of cardiac mass and myofiber hypertrophy
Y Seta, T Kanda, T Yokoyama, et al.
Current Opinion in Cardiology
|
May 1, 1997
The role of cytokines in disease progression in heart failure
K Shan, K Kurrelmeyer, Y Seta, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|
January 1, 1992
Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations
S Borsadia, A H Ghanem, Y Seta, et al.
Proceedings of the Association of American Physicians
|
October 16, 1999
Cytokines in heart failure: pathogenetic mechanisms and potential treatment
Z Dibbs, K Kurrelmeyer, D Kalra, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Circulation
|
September 12, 2000
Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway
D Kalra, G Baumgarten, Z Dibbs, et al.
Biochemical and Biophysical Research Communications
|
October 23, 1997
Keratinocytes become terminally differentiated in a process involving programmed cell death
Y Maruoka, H Harada, T Mitsuyasu, et al.
Circulation
|
March 10, 2001
Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart
F Wang, Y Seta, G Baumgarten, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 10, 2014
Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes
T Lajunen, K Hisazumi, T Kanazawa, et al.
Circulation
|
June 29, 1999
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
A Deswal, B Bozkurt, Y Seta, et al.
Research Communications in Molecular Pathology and Pharmacology
|
January 5, 2002
Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression
Y Seta, T Kanda, T Tanaka, et al.
Japanese Heart Journal
|
May 12, 2000
Therapy with the nonpeptide endothelin receptor antagonist 97-139 in a murine model of congestive heart failure: reduction of cardiac mass and myofiber hypertrophy
Y Seta, T Kanda, T Yokoyama, et al.
Current Opinion in Cardiology
|
May 1, 1997
The role of cytokines in disease progression in heart failure
K Shan, K Kurrelmeyer, Y Seta, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|
January 1, 1992
Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations
S Borsadia, A H Ghanem, Y Seta, et al.
Proceedings of the Association of American Physicians
|
October 16, 1999
Cytokines in heart failure: pathogenetic mechanisms and potential treatment
Z Dibbs, K Kurrelmeyer, D Kalra, et al.
Page
of 4